Abstract
Circulating levels of YKL-40 and interleukin 6 (IL-6) are elevated in patients with type 2 diabetes. We aimed to evaluate YKL-40 levels in patients with chronic pancreatitis (CP) with and without secondary diabetes mellitus (DM) to investigate whether elevated plasma YKL-40 could play a primary role in the pathogenesis of type 2 diabetes or rather represent a consequence of the diabetic state.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Pancreas |
Vol/bind | 41 |
Udgave nummer | 8 |
Sider (fra-til) | 1316-8 |
Antal sider | 3 |
ISSN | 0885-3177 |
DOI | |
Status | Udgivet - 2012 |